CA-ANDERSEN-GLOBAL
Efter at have opereret under navnene Andersen Tax, Andersen Legal og Andersen Tax & Legal vil medlemmerne af Andersen Global i Europa nu operere under et enkelt brand: ”Andersen”, hvilket viser det globale skatte- og advokatfirmas harmoniserede og homogene tilgang. Der vil ske lignende brandændringer i andre regioner rundt om i verden året igennem.
Denne bekendtgørelse kommer i hælene på de amerikanske medlemsfirmaers overgang til brandet ”Andersen” fra ”Andersen Tax” sidste år. I alt vil medlemsfirmaer i 12 europæiske lande – Cypern, Tyskland, Grækenland, Ungarn, Irland, Italien, Luxembourg, Polen, Portugal, Spanien, Schweitz og Storbritannien – tage Andersen-brandet til sig. Overgangen af OrienTax og Szabo Keleman & Partners markerer introduktionen af Andersen-brandet i Ungarn. Derudover vil B.A Tax Accountants tage brandet til sig, når de bliver en del af teamet i Luxembourg.
Inden for Europa er Andersen Global også til stede i Østrig, Bosnien og Herzegovina, Bulgarien, Kroatien, Kazakhstan, Moldova, Nederlandene, Nordmakedonien, Republikken Kosovo, Rumænien, Serbien, Slovakiet, Slovenien og Ukraine gennem sine samarbejdende firmaer og har planer om i fremtiden at udvide sit regionale fodaftryk i Central- og Østeuropa samt Skandinavien.
Optagelsen af Andersen-brandet i Europa er den bedste repræsentant for den komplette pakke af tjenester, som organisationen tilbyder sine kunder internationalt, inkl. juridiske tjenester i 86 lande, hvoraf 23 er i Europa.
”Vores fælles brand, Andersen, afspejler vores »én samlet virksomhed«-kultur og omfatter alt, hvad vi foretager os som en global organisation. Det kendetegner vores evne til at levere den bedste service indenfor branchen og vores dybe engagement i investering i vores folk,” siger Mark Vorsatz, formand for Andersen Global og administrerende direktør i Andersen. ”Hvert eneste medlem og samarbejdende firma, der er del af vores organisation, fremmer forvaltning og bibeholder gennemsigtighed. Vores globale organisation fortsætter med at været drevet af kunders behov og erkendelsen af, at vi bedst servicerer vores kunder med uafhængige og sammenhængende tjenester.”
Overgangen til Andersen-brandet i Europa er en milepæl for den globale organisation, som tog sin begyndelse i 2002, da 23 forhenværende Arthur Andersen skattepartnere skabte skattefirmaet WTAS. I 2014 tog gruppen brandet Andersen Tax til sig, da det bedst repræsenterede firmaets værdier, kunden først- kultur, forvaltning og gennemsigtighed. Organisationen er vokset eksponentielt siden etableringen af Andersen Global (tidligere WTAS Global) af det amerikanske grundlæggermedlem Andersen Tax LLC i 2013. Den europæiske region begyndte med kun to steder i 2013 og er siden vokset til mere end 50 steder, med flere end 2.000 skatte- og juridiske rådgivere og flere end 300 partnere i dag.
”Mange lande og regioner, såsom Storbritannien, presser på for at revisionsfirmaer adskiller deres revisions- og skattepraksis for at sikre integritet og uafhængighed,” siger Paolo Mondia, Co-Regional Managing Director in Europa. ”Vi har et konkurrencemæssigt forspring på det europæiske marked, hvor kombinerede skatte- og juridiske tjenester på uafhængig vis hører til undtagelsen, og vores kunder har været ekstremt modtagelige overfor denne model.”
Andrea De Vecchi, Co-Regional Managing Director in Europe, tilføjer: ”Ved at yde både juridiske og skattemæssige tjenester har vi været i stand til at udvide vores regionale og globale fodaftryk, forbedre vores serviceudbud og få fordelene og ressourcerne fra et globalt firma til vores kunder på en gnidningsfri måde.”
Gennem hele 2020 medlemsfirmaer over hele verden vil optage Andersen-brandet, mens den globale organisation vil fortsætte med at give mere dybde på afgørende markeder, herunder Afrika og Mellemøsten. Det er visionen at udvikle en gnidningsfri, professionel tjenestemodel med den bedste service i branchen rundt om i verden.
Andersen Global er en international sammenslutning af juridisk separate, uafhængige medlemsfirmaer, bestående af skatte- og juraeksperter fra hele verden. Siden oprettelsen i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 5.000 eksperter globalt og er repræsenteret på over 177 lokaliteter via sine medlems- og samarbejdsfirmaer.
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20200709005432/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
